Cambridge Trust Company »

Cerevel Therapeutics Hldng I shares owned by Cambridge Trust Company

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Cambridge Trust Company from 13F filings

Historical chart of Cambridge Trust Company investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Cambridge Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Cambridge Trust Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 250 42.40

More positions owned by Cambridge Trust Company

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
iShares ETFs/USA 7-10 Yr Trsy Bd (IEF)
Amazon (AMZN)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Broadcom (AVGO)
Ishares Core S&p500 Etf (IVV)
Berkshire Hathaway Cl A (BRK.A)
UnitedHealth (UNH)
JP Morgan ETFs/USA Equity Premium (JEPI)
Procter & Gamble Company (PG)
Linde SHS (LIN)

View all positions for Cambridge Trust Company

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I